TRANSLOCATED INTIMIN RECEPTORS (TIR) OF SHIGA-TOXIGENIC ESCHERICHIA-COLI ISOLATES BELONGING TO SEROGROUPS O26, O111, AND O157 REACT WITH SERA FROM PATIENTS WITH HEMOLYTIC-UREMIC SYNDROME AND EXHIBIT MARKED SEQUENCE HETEROGENEITY

Citation
Aw. Paton et al., TRANSLOCATED INTIMIN RECEPTORS (TIR) OF SHIGA-TOXIGENIC ESCHERICHIA-COLI ISOLATES BELONGING TO SEROGROUPS O26, O111, AND O157 REACT WITH SERA FROM PATIENTS WITH HEMOLYTIC-UREMIC SYNDROME AND EXHIBIT MARKED SEQUENCE HETEROGENEITY, Infection and immunity (Print), 66(11), 1998, pp. 5580-5586
Citations number
33
Categorie Soggetti
Immunology,"Infectious Diseases
ISSN journal
00199567
Volume
66
Issue
11
Year of publication
1998
Pages
5580 - 5586
Database
ISI
SICI code
0019-9567(1998)66:11<5580:TIR(OS>2.0.ZU;2-0
Abstract
The capacity to form attaching and effacing (A/E) lesions on the surfa ces of enterocytes is an important virulence trait of several enteric pathogens, including enteropathogenic Escherichia coli (EPEC) and Shig a-toxigenic E. coli (STEC). Formation of such lesions depends upon an interaction between a bacterial outer membrane protein (intimin) and a bacterially encoded receptor protein (Tir) which is exported from the bacterium and translocated into the host cell membrane. Intimin, Tir, and several other proteins necessary for generation of A/E lesions ar e encoded on a chromosomal pathogenicity island termed the locus for e nterocyte effacement (LEE). Reports of sequence heterogeneity and anti genic variation in the region of intimin believed to be responsible fo r receptor binding raise the possibility that the receptor itself is a lso heterogeneous. We have examined this by cloning and sequencing tir genes from three different STEC strains belonging to serogroups O26, O111, and O157. The deduced amino acid sequences for the Tir homologue s from these strains varied markedly, exhibiting only 65.4, 80.2, and 56.7% identity, respectively, to that recently reported for EPEC Tir. STEC Tir is also highly immunogenic in humans. Western blots off. coli DH5 alpha expressing the various STEC tir genes cloned in pBluescript [but not E. coli DH5 alpha(pBluescript)] reacted strongly with conval escent sera from patients with hemolytic-uremic syndrome (HUS) caused by known LEE-positive STEC. Moreover, no reaction was seen when the va rious clone lysates were probed with serum from a patient with HUS cau sed by a LEE-negative STEC or with serum from a healthy individual. Co variation of exposed epitopes on both intimin and Tir may be a means w hereby STEC avoid host immune responses without compromising adhesin-r eceptor interaction.